A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Conditions:   Neoplasms;   Child;   Adolescent Interventions:   Drug: Ramucirumab;   Drug: Cyclophosphamide;   Drug: Vinorelbine;   Drug: Gemcitabine;   Drug: Docetaxel;   Drug: Abemaciclib;   Drug: Irinotecan;   Drug: Temozolomide Sponsor:   Eli Lilly and Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Writing Intervention With Adolescents and Young Adults With Cancer
Conditions:   Cancer Patients;   Communication Research Interventions:   Behavioral: Writing;   Behavioral: Interview Sponsor:   St. Jude Children's Research Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2023 Category: Research Source Type: clinical trials